558 related articles for article (PubMed ID: 24563222)
1. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
Jørgensen KJ; Gøtzsche PC; Dalbøge CS; Johansen HK
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD004707. PubMed ID: 24563222
[TBL] [Abstract][Full Text] [Related]
2. Voriconazole versus amphotericin B in cancer patients with neutropenia.
Jørgensen KJ; Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2006 Jan; (1):CD004707. PubMed ID: 16437492
[TBL] [Abstract][Full Text] [Related]
3. Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients.
Johansen HK; Gøtzsche PC
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD000239. PubMed ID: 25188769
[TBL] [Abstract][Full Text] [Related]
4. Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients.
Johansen HK; Gøtzsche PC
Cochrane Database Syst Rev; 2002; (2):CD000239. PubMed ID: 12076388
[TBL] [Abstract][Full Text] [Related]
5. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections.
Blyth CC; Hale K; Palasanthiran P; O'Brien T; Bennett MH
Cochrane Database Syst Rev; 2010 Feb; 2010(2):CD006343. PubMed ID: 20166083
[TBL] [Abstract][Full Text] [Related]
6. Amphotericin B vs fluconazole for controlling fungal infections in neutropenic cancer patients.
Johansen HK; Gotzsche PC
Cochrane Database Syst Rev; 2000; (3):CD000239. PubMed ID: 10908468
[TBL] [Abstract][Full Text] [Related]
7. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
Walsh TJ; Pappas P; Winston DJ; Lazarus HM; Petersen F; Raffalli J; Yanovich S; Stiff P; Greenberg R; Donowitz G; Schuster M; Reboli A; Wingard J; Arndt C; Reinhardt J; Hadley S; Finberg R; Laverdière M; Perfect J; Garber G; Fioritoni G; Anaissie E; Lee J;
N Engl J Med; 2002 Jan; 346(4):225-34. PubMed ID: 11807146
[TBL] [Abstract][Full Text] [Related]
8. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
Moen MD; Lyseng-Williamson KA; Scott LJ
Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
[TBL] [Abstract][Full Text] [Related]
9. Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.
Kullberg BJ; Sobel JD; Ruhnke M; Pappas PG; Viscoli C; Rex JH; Cleary JD; Rubinstein E; Church LW; Brown JM; Schlamm HT; Oborska IT; Hilton F; Hodges MR
Lancet; 2005 Oct 22-28; 366(9495):1435-42. PubMed ID: 16243088
[TBL] [Abstract][Full Text] [Related]
10. Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?
Pagano L; Valentini CG; Fianchi L; Caira M
J Chemother; 2011 Feb; 23(1):5-8. PubMed ID: 21482486
[TBL] [Abstract][Full Text] [Related]
11. Routine versus selective antifungal administration for control of fungal infections in patients with cancer.
Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD000026. PubMed ID: 25188768
[TBL] [Abstract][Full Text] [Related]
12. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.
Malik IA; Moid I; Aziz Z; Khan S; Suleman M
Am J Med; 1998 Dec; 105(6):478-83. PubMed ID: 9870832
[TBL] [Abstract][Full Text] [Related]
13. Nystatin prophylaxis and treatment in severely immunodepressed patients.
Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002033. PubMed ID: 25188770
[TBL] [Abstract][Full Text] [Related]
14. Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.
Viscoli C; Castagnola E; Van Lint MT; Moroni C; Garaventa A; Rossi MR; Fanci R; Menichetti F; Caselli D; Giacchino M; Congiu M
Eur J Cancer; 1996 May; 32A(5):814-20. PubMed ID: 9081359
[TBL] [Abstract][Full Text] [Related]
15. Review: voriconazole for prevention or treatment of invasive fungal infections in cancer with neutropenia.
Morris AM
Ann Intern Med; 2014 Jul; 161(2):JC8. PubMed ID: 25023274
[No Abstract] [Full Text] [Related]
16. [Current indications for voriconazole in onco-hematological patients].
Jarque I; Sanz MA
Rev Iberoam Micol; 2007 Sep; 24(3):213-6. PubMed ID: 17874858
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer.
Winston DJ; Hathorn JW; Schuster MG; Schiller GJ; Territo MC
Am J Med; 2000 Mar; 108(4):282-9. PubMed ID: 11014720
[TBL] [Abstract][Full Text] [Related]
18. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
Cortegiani A; Russotto V; Maggiore A; Attanasio M; Naro AR; Raineri SM; Giarratano A
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD004920. PubMed ID: 26772902
[TBL] [Abstract][Full Text] [Related]
19. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
[TBL] [Abstract][Full Text] [Related]
20. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
Playford EG; Webster AC; Sorrell TC; Craig JC
Cochrane Database Syst Rev; 2006 Jan; (1):CD004920. PubMed ID: 16437504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
